Analysis on the medication rule of traditional Chinese medicine in the treatment of COVID-19 patients.

Acupuncture and herbal medicine Pub Date : 2022-06-01 Epub Date: 2022-06-17 DOI:10.1097/HM9.0000000000000030
Xiaoyu Tan, Qingqing Yang, Xianming Cai, Yiming Tao, Suyu Gao, Lixia He, Yubin Zhao, Siyan Zhan, Hong Cheng, Haibo Song, Feng Sun
{"title":"Analysis on the medication rule of traditional Chinese medicine in the treatment of COVID-19 patients.","authors":"Xiaoyu Tan, Qingqing Yang, Xianming Cai, Yiming Tao, Suyu Gao, Lixia He, Yubin Zhao, Siyan Zhan, Hong Cheng, Haibo Song, Feng Sun","doi":"10.1097/HM9.0000000000000030","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To describe patterns of utilization of traditional Chinese medicine (TCM) in the treatment of patients with coronavirus disease 2019 (COVID-19).</p><p><strong>Methods: </strong>Adult patients with COVID-19 who received TCM treatment were divided into a non-serious group (mild and moderate types) and a serious group (severe and critical types) according to their admission conditions. The medical records and prescriptions of these patients were investigated to determine their TCM utilization patterns.</p><p><strong>Results: </strong>In all, 3,872 COVID-19 patients were included. Oral Chinese traditional patent medicine (CPM) was the most commonly used type of TCM, followed by decoction. The proportion of multi-drug combinations was higher than single drug use (55.0% <i>vs.</i> 45.0%). Decoction combined with oral CPM was the most common combination (39.1%, 1,514/3,872). Orally administered, injected, and externally applied CPM were significantly more common in the serious group than in the non-serious, while decoction and non-drug TCM treatments were more common in the non-serious than in the serious group. Multi-drug combinations were used for the majority of patients in both groups, mainly in the form of decoctions combined with oral CPM. Among the serious patients, injected CPM was more often used in patients who died during treatment (35.0%, 36/103). The two most common medication patterns were decoction combined with oral CPM and oral CPM alone in the two finally discharged groups. Oral CPM alone or used in combination with injected CPM were seen most commonly in the death group. Significant differences were established in TCM utilization and medication patterns among patients in three groups who had different prognoses and outcomes.</p><p><strong>Conclusions: </strong>The treatment measures and medication patterns of TCM commonly used in COVID-19 patients with the range of conditions found in this study should be further explored in the future to provide a more complete reference for COVID-19 treatment.</p>","PeriodicalId":93856,"journal":{"name":"Acupuncture and herbal medicine","volume":"2 2","pages":"91-98"},"PeriodicalIF":0.0000,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/fb/02/hm9-2-91.PMC9407178.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acupuncture and herbal medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/HM9.0000000000000030","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/6/17 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To describe patterns of utilization of traditional Chinese medicine (TCM) in the treatment of patients with coronavirus disease 2019 (COVID-19).

Methods: Adult patients with COVID-19 who received TCM treatment were divided into a non-serious group (mild and moderate types) and a serious group (severe and critical types) according to their admission conditions. The medical records and prescriptions of these patients were investigated to determine their TCM utilization patterns.

Results: In all, 3,872 COVID-19 patients were included. Oral Chinese traditional patent medicine (CPM) was the most commonly used type of TCM, followed by decoction. The proportion of multi-drug combinations was higher than single drug use (55.0% vs. 45.0%). Decoction combined with oral CPM was the most common combination (39.1%, 1,514/3,872). Orally administered, injected, and externally applied CPM were significantly more common in the serious group than in the non-serious, while decoction and non-drug TCM treatments were more common in the non-serious than in the serious group. Multi-drug combinations were used for the majority of patients in both groups, mainly in the form of decoctions combined with oral CPM. Among the serious patients, injected CPM was more often used in patients who died during treatment (35.0%, 36/103). The two most common medication patterns were decoction combined with oral CPM and oral CPM alone in the two finally discharged groups. Oral CPM alone or used in combination with injected CPM were seen most commonly in the death group. Significant differences were established in TCM utilization and medication patterns among patients in three groups who had different prognoses and outcomes.

Conclusions: The treatment measures and medication patterns of TCM commonly used in COVID-19 patients with the range of conditions found in this study should be further explored in the future to provide a more complete reference for COVID-19 treatment.

Abstract Image

新冠肺炎患者中医用药规律分析。
目的:探讨2019冠状病毒病(新冠肺炎)患者中医药应用模式。对这些患者的病历和处方进行调查,以确定他们的中医药使用模式。结果:共纳入3872名新冠肺炎患者。口服中成药是最常用的中药类型,其次是汤剂。多药联合用药的比例高于单药(55.0%对45.0%),其中以汤剂联合口服CPM的比例最高(39.1%,1514/3872)。口服、注射和外敷CPM在严重组中明显比非严重组更常见,而煎剂和非药物中药治疗在非严重组中比严重组更普遍。两组的大多数患者都使用了多种药物组合,主要是以煎剂结合口服CPM的形式。在重症患者中,注射CPM更常用于治疗期间死亡的患者(35.0%,36/103)。两个最终出院组中最常见的两种用药模式是汤剂联合口服CPM和单独口服CPM。单独口服CPM或与注射CPM联合使用在死亡组中最常见。在具有不同预后和结果的三组患者中,在中医药利用和用药模式方面存在显著差异。结论:本研究发现的新冠肺炎患者的中医药治疗措施和用药模式有待进一步探索,为新冠肺炎的治疗提供更完整的参考。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信